Emerging possibilities in the development and function of regulatory T cells

被引：116

作者：

Wing, Kajsa

Fehervari, Zoltan

Sakaguchi, Shimon

机构：

[1] Kyoto Univ, Inst Frontier Med Sci, Dept Expt Pathol, Sakyo Ku, Kyoto 6068507, Japan

[2] CREST, Japan Sci & Technol Agcy, Kawaguchi 3320012, Japan

来源：

INTERNATIONAL IMMUNOLOGY | 2006年 / 18卷 / 07期

关键词：

adaptive regulatory T cell; CTLA-4; Foxp3; natural regulatory T cells; tolerance;

D O I：

10.1093/intimm/dxl044

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

CD25(+)CD4(+) Regulatory T cells (Treg) represent a unique population of lymphocytes capable of powerfully suppressing immune responses. A large body of experimental data have now confirmed the essential role played by these cells in a host of clinically relevant areas such as self-tolerance, transplantation, allergy and tumor/microbial immunity. Despite this mass of knowledge, significant gaps in our understanding of fundamental Treg biology remain, particularly regarding their development and mechanisms of suppression. In this review we attempt to highlight the current controversies and directions in which this exciting field is moving.

引用

收藏

页码：991 / 1000

页数：10

相关论文

共 122 条

[1] Reduced transforming growth factor-β1 production by mononuclear cells from patients with active chronic idiopathic thrombocytopenic purpura [J].

Andersson, PO ;

Olsson, A ;

Wadenvik, H .

BRITISH JOURNAL OF HAEMATOLOGY, 2002, 116 (04) :862-867

[2] Phenotype, localization, and mechanism of suppression of CD4+CD25+ human thymocytes [J].

Annunziato, F ;

Cosmi, L ;

Liotta, F ;

Lazzeri, E ;

Manetti, R ;

Vanini, V ;

Romagnani, P ;

Maggi, E ;

Romagnani, S .

JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (03) :379-387

[3] In vivo instruction of suppressor commitment in naive T cells [J].

Apostolou, I ;

von Boehmer, H .

JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 199 (10) :1401-1408

[4] An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation [J].

Asseman, C ;

Mauze, S ;

Leach, MW ;

Coffman, RL ;

Powrie, F .

JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (07) :995-1003

[5]

Azuma T, 2003, CANCER RES, V63, P4516

[6] Inhibition of human CD4+CD25+high regulatory T cell function [J].

Baecher-Allan, C ;

Viglietta, V ;

Hafler, DA .

JOURNAL OF IMMUNOLOGY, 2002, 169 (11) :6210-6217

[7] CD4+CD25high regulatory cells in human peripheral blood [J].

Baecher-Allan, C ;

Brown, JA ;

Freeman, GJ ;

Hafler, DA .

JOURNAL OF IMMUNOLOGY, 2001, 167 (03) :1245-1253

[8] In vitro generation of interleukin 10-producing regulatory CD4+ T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines [J].

Barrat, FJ ;

Cua, DJ ;

Boonstra, A ;

Richards, DF ;

Crain, C ;

Savelkoul, HF ;

de Waal-Malefyt, R ;

Coffman, RL ;

Hawrylowicz, CM ;

O'Garra, A .

JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 195 (05) :603-616

[9] CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity [J].

Belkaid, Y ;

Piccirillo, CA ;

Mendez, S ;

Shevach, EM ;

Sacks, DL .

NATURE, 2002, 420 (6915) :502-507

[10] Major histocompatibility complex class II-positive cortical epithelium mediates the selection of CD4+25+ immunoregulatory T cells [J].

Bensinger, SJ ;

Bandeira, A ;

Jordan, MS ;

Caton, AJ ;

Laufer, TM .

JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (04) :427-438

← 1 2 3 4 5 6 7 8 9 10 →